S&P Futures
5,886.50 -6.00 (-0.10%) Dow Futures
43,037.00 -132.00 (-0.31%) Nasdaq Futures
20,513.00 -29.00 (-0.14%) Russell 2000 Futures
2,244.40 -1.80 (-0.08%) Crude Oil
72.24 +0.15 (+0.21%) Gold
2,759.20 -0.60 (-0.02%)
Unity Biotechnology, Inc. (UBX)
After hours:
| Previous Close | 1.4000 |
| Open | 1.4000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 1.3805 - 1.4000 |
| 52 Week Range | 1.2200 - 2.2600 |
| Volume | |
| Avg. Volume | 39,989 |
| Market Cap | 23.587M |
| Beta (5Y Monthly) | 0.83 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.9200 |
| Earnings Date | Nov 11, 2024 - Nov 15, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.67 |
GlobeNewswireUNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024
SAN FRANCISCO, Sept. 24, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that it will host an in-person and virtual event for investors and analysts on Tuesday, October 15, 2024, at 8:00 a.m. ET in New York, NY. The event will feature presentations from prominent ophthalmology key opinion leaders (KOLs) and company management. UNITY Biotechnology Ophthalmology D
- GlobeNewswire
UNITY Biotechnology to Participate in Upcoming Investor Conferences
SAN FRANCISCO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that members of its senior management team will provide a corporate update and participate in one-on-one meetings at the following investor conferences. H.C. Wainwright 4th Annual Ophthalmology Virtual ConferencePresentation Date and Time: Thursday, August 15, 2024 at 7:00 a.m. ETLocation: V
